About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
Speaker: Prof. Jesús Francisco Bermejo Martín. MD PhD Professor (PPL), Medicine Dept, Universidad de Salamanca (USAL). Principal Investigator, BioSepsis (Translational Research in Severe Infections) - IBSAL / USAL / CIBERES / EGIS.
Classical perspectives approaching the understanding of sepsis physiopathogenesis propose over-simplified models depicting the existence of “phases” (inflammatory / immunosuppression) occurring in either a sequential or a simultaneous manner. These “one-size-fits-all” models do not capture the complexity of sepsis, which is characterised by a large variety of clinical presentations, responding probably to different biological events in each individual patient. In our view, the “original sin” of sepsis is the inability of the host to control the pathogen using balanced responses which prevent damage to the tissues. The severity of sepsis at presentation would be determined indeed by the interplay between the performance of the immune system to control the pathogen and the degree of tissue damage caused to do so. This balance is heavily influenced by the existence of prior comorbidities, basal immunosuppression, aging and sepsis treatment. This talk will propose thus a new provocative perspective on how sepsis pathogenesis should be approached, a new perspective that moves beyond the “phases” based models to a more personalised model considering together microbial, host response and tissue damage parameters to define the true individual biological status of each case of sepsis at presentation and along its clinical course. This new model should be taken into account to personalise treatment in this severe condition.
Host: Dr. Juan Carlos Ruiz, Shock, Organ Dysfunction and Resuscitation. VHIR. Intensive Care Medicine, General Hospital
Online assistance: https://gencat.zoom.us/j/88449511660